ERBB2 and breast cancer: Similarly, the calcitriol analog EB1089 enhanced the antiproliferative response of HER2-positive breast cancer cells when added to lapatinib–antiestrogen combinations, partly by regulating ERα protein expression and decreasing AKT phosphorylation [28].